Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
| Main Authors: | Burnham, S., Bourgeat, P., Dore, V., Savage, G., Brown, B., Laws, Simon, Maruff, P., Salvado, O., Ames, D., Martins, R., Masters, C., Rowe, C., Villemagne, V. |
|---|---|
| Format: | Journal Article |
| Published: |
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/42034 |
Similar Items
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
by: Porter, T., et al.
Published: (2018)
by: Porter, T., et al.
Published: (2018)
Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease
by: Porter, T., et al.
Published: (2019)
by: Porter, T., et al.
Published: (2019)
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)
by: Pike, K., et al.
Published: (2011)
A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease
by: Porter, T., et al.
Published: (2018)
by: Porter, T., et al.
Published: (2018)
BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF
by: Lim, Y., et al.
Published: (2017)
by: Lim, Y., et al.
Published: (2017)
Amyloid ß–associated cognitive decline in the absence of clinical disease progression and systemic illness
by: Harrington, K., et al.
Published: (2017)
by: Harrington, K., et al.
Published: (2017)
KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aß-amyloid burden
by: Porter, T., et al.
Published: (2018)
by: Porter, T., et al.
Published: (2018)
Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)
by: Verdile, Giuseppe, et al.
Published: (2014)
Insights into the pathophysiology of Alzheimers disease and potential therapeutic targets: a current perspective
by: Rajah Kumaran, Kesevan, et al.
Published: (2023)
by: Rajah Kumaran, Kesevan, et al.
Published: (2023)
Insights into the pathophysiology of Alzheimer's disease and potential therapeutic targets: a current perspective
by: Kesevan, Rajah Kumaran, et al.
Published: (2023)
by: Kesevan, Rajah Kumaran, et al.
Published: (2023)
Chemicals used for the induction of Alzheimers disease-like cognitive dysfunctions in rodents
by: Mahdi, Onesimus, et al.
Published: (2019)
by: Mahdi, Onesimus, et al.
Published: (2019)
Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults
by: Laws, S., et al.
Published: (2017)
by: Laws, S., et al.
Published: (2017)
Plasma lipoprotein b-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
by: Mamo, John, et al.
Published: (2008)
by: Mamo, John, et al.
Published: (2008)
Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)
by: Lui, J., et al.
Published: (2010)
ß-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
by: Holmes, S., et al.
Published: (2016)
by: Holmes, S., et al.
Published: (2016)
Relationship of Cognition and Alzheimer’s Disease with Gastrointestinal Tract Disorders: A Large-Scale Genetic Overlap and Mendelian Randomisation Analysis
by: Adewuyi, Emmanuel, et al.
Published: (2022)
by: Adewuyi, Emmanuel, et al.
Published: (2022)
Diet and Alzheimer's disease
by: Creegan, R., et al.
Published: (2013)
by: Creegan, R., et al.
Published: (2013)
Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)
by: Chen, M., et al.
Published: (2014)
Alzheimer's disease talk
by: The Star,
Published: (2012)
by: The Star,
Published: (2012)
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)
by: Martins, R., et al.
Published: (2018)
Genomic Characterisation of the Relationship and Causal Links Between Vascular Calcification, Alzheimer’s Disease, and Cognitive Traits
by: Adewuyi, Emmanuel
Published: (2025)
by: Adewuyi, Emmanuel
Published: (2025)
The role of endocannabinoids in Alzheimer's disease
by: Maroof, Nazia
Published: (2013)
by: Maroof, Nazia
Published: (2013)
Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)
by: Newman, M., et al.
Published: (2017)
Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)
by: Verdile, Giuseppe, et al.
Published: (2009)
Consumption of fish and Alzheimer's Disease
by: Newton, Wendy, et al.
Published: (2011)
by: Newton, Wendy, et al.
Published: (2011)
Aß aggregation and possible implications in Alzheimer's disease pathogenesis
by: Bharadwaj, Prashant, et al.
Published: (2009)
by: Bharadwaj, Prashant, et al.
Published: (2009)
Assessing genetic overlap of Alzheimer’s disease with type 2 diabetes
by: Adewuyi, Emmanuel, et al.
Published: (2025)
by: Adewuyi, Emmanuel, et al.
Published: (2025)
Charles Bonnet Syndrome: A Precursor To Alzheimer Disease
by: Janaki V.,, et al.
Published: (2015)
by: Janaki V.,, et al.
Published: (2015)
Effects of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial
by: Lautenschlager, N., et al.
Published: (2008)
by: Lautenschlager, N., et al.
Published: (2008)
Identifying the mechanism to forecast the progression of Alzheimer’s disease from mild cognitive impairment using deep learning
by: Hiu, Theresa Wei Xin
Published: (2022)
by: Hiu, Theresa Wei Xin
Published: (2022)
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
by: Steele, J., et al.
Published: (2013)
by: Steele, J., et al.
Published: (2013)
Changes in Brain Transcripts Related to Alzheimer’s Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer’s Disease Risk
by: Johnstone, D., et al.
Published: (2012)
by: Johnstone, D., et al.
Published: (2012)
Investigating genetic variation in Alzheimer’s disease
by: Patel, Tulsi
Published: (2018)
by: Patel, Tulsi
Published: (2018)
The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)
by: Barron, A., et al.
Published: (2010)
The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)
by: Verdile, Giuseppe, et al.
Published: (2019)
A review of lexical retrieval intervention in primary progressive aphasia and Alzheimer’s disease: mechanisms of change, generalisation, and cognition
by: Beales, A., et al.
Published: (2018)
by: Beales, A., et al.
Published: (2018)
Investigating the Relationships Between Insulin Resistance, Cognitive Function and Alzheimer’s Disease Biomarkers and Exploring the Potential Benefits of an Insulin Mimetic.
by: Woodfield, Amy Marie
Published: (2024)
by: Woodfield, Amy Marie
Published: (2024)
Genetic underpinnings in Alzheimer’s disease –
A review
by: Moustafa, Ahmed A., et al.
Published: (2017)
by: Moustafa, Ahmed A., et al.
Published: (2017)
The genetics of Alzheimer's disease: putting flesh on the bones
by: Medway, C., et al.
Published: (2014)
by: Medway, C., et al.
Published: (2014)
Investigation into patterns of epigenetic regulation of Alzheimer’s disease
by: Boden, Kirsty
Published: (2019)
by: Boden, Kirsty
Published: (2019)
Similar Items
-
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
by: Porter, T., et al.
Published: (2018) -
Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease
by: Porter, T., et al.
Published: (2019) -
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011) -
A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease
by: Porter, T., et al.
Published: (2018) -
BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF
by: Lim, Y., et al.
Published: (2017)